Pre-earnings options volume in Actinium Pharmaceuticals is normal with calls leading puts 3:2. Implied volatility suggests the market is anticipating a move near 7.3%, or 92c, after results are released. Median move over the past eight quarters is 3.0%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ATNM: